Skip to content

Bioventus BVS Raw materials

Raw materials at other companies

Artivion logo
ArtivionAORT
$37.9M+9.9%
Enovis logo
EnovisENOV
$119.22M+17.9%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$90.2M-3.3%
Avanos Medical logo
Avanos MedicalAVNS
$34.1M-8.8%
Medtronic logo
MedtronicMDT
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndSupplies.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's raw materials?
Bioventus (BVS) reported raw materials of $19.3M in Q1 2026.
How has Bioventus's raw materials changed year-over-year?
Bioventus's raw materials decreased by 15.5% year-over-year, from $22.84M to $19.3M.
What is the long-term trend for Bioventus's raw materials?
Over 5 years (2020 to 2025), Bioventus's raw materials has grown at a 42.1% compound annual growth rate (CAGR), from $3.67M to $21.24M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.